P31 Patients treated with the pipeline shield flow diverter enrolled within the INSPIRE study: primary analysis

ConclusionThe primary analysis of the INSPIRE study is still ongoing. During the conference, we will provide safety and efficacy data on a large and heterogenous patient population treated with the Pipeline Shield device, with adjudication by CEC and Imaging Core Lab ensuring high quality of these data.ReferencesPeriprocedural Outcomes and Early Safety with the use of the Pipeline Flex Embolization Device with Shield Technology for Unruptured Intracranial Aneurysms: Preliminary Results from a Prospective Clinical Study. J Neurointerv Surg, 2017 Do you have any conflict of interest to declare?: YesConflict of Interest StatementInvestigator in INSPIRE Registry, Consultant for MEdtronic NV

Source: Journal of NeuroInterventional Surgery - August 29, 2022 Category: Neurosurgery Authors: Szikora, I., Turjman, F., Spelle, L., Holtmanspötter, M., Martinez-Galdamez, M., Lamin, S., Fiehler, J. Tags: 14th Congress of the European Society of Minimally Invasive Neurological Therapy 2022 Meeting Abstracts Source Type: research